APO RESEARCH · REPORT
Mupirocin Ointment
Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.
Product & engineering
Understand the product.
Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.
Selected research
Industry Research
Mupirocin Ointment Industry Research Report 2026
Market perspective
Mupirocin is an antibiotic that prevents bacteria from growing on skin. Mupirocin Ointment (for use on the skin) is used to treat skin infections such as impetigo (IM-pe-TYE-go) or a "Staph" infection of the skin.
Currently, global production of Mupirocin Ointment is concentrated as there are few manufacturers engaged in the industry. The largest manufacturer is Glenmark Pharms, who owns 37% revenue market share.
As for the region, North America is the largest consumption region, holding 35% revenue market share, followed by China, with 22% market share.
Read the full market overview
Mupirocin Ointment is used to treat certain skin infections (such as impetigo). It is an antibiotic. It works by stopping the growth of certain bacteria. Among various applications, demand from Retail Pharmacy is the largest one.
Above 20g Mupirocin Ointment accounted for a major share of 30% the global Mupirocin Ointment market.
Report Scope
This report quantifies the global Mupirocin Ointment market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Mupirocin Ointment Market by Company
Glenmark Pharms
Glaxosmithkline
SmithKline & French
Humanwell Healthcare
Taro Pharmaceutical
Teva
Perrigo
Hanzhou Zhuyangxin Pharmaceutical
Mupirocin Ointment Segment by Type
Below 10g
10g-20g
Above 20g
Mupirocin Ointment Segment by Sales Channel
Hospital
Retail Pharmacy
Others
Mupirocin Ointment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mupirocin Ointment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mupirocin Ointment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mupirocin Ointment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Mupirocin Ointment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Mupirocin Ointment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Mupirocin Ointment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by sales channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Below 10g
- 10g-20g
- Above 20g
Applications
- Hospital
- Retail Pharmacy
- Others
Companies covered
- Glenmark Pharms
- Glaxosmithkline
- SmithKline & French
- Humanwell Healthcare
- Taro Pharmaceutical
- Teva
- Perrigo
- Hanzhou Zhuyangxin Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Mupirocin Ointment Market Size (2021-2032)
- 2.2.2 Global Mupirocin Ointment Sales (2021-2032)
- 2.2.3 Global Mupirocin Ointment Market Average Price (2021-2032)
- 2.3 Mupirocin Ointment by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Below 10g
- 2.3.3 10g-20g
- 2.3.4 Above 20g
- 2.4 Mupirocin Ointment by Sales Channel
- 2.4.1 Market Value Comparison by Sales Channel (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Retail Pharmacy
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Mupirocin Ointment Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Mupirocin Ointment Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Mupirocin Ointment Revenue of Manufacturers (2021-2026)
- 3.4 Global Mupirocin Ointment Average Price by Manufacturers (2021-2026)
- 3.5 Global Mupirocin Ointment Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Mupirocin Ointment, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Mupirocin Ointment, Product Type & Application
- 3.8 Global Manufacturers of Mupirocin Ointment, Established Date
- 3.9 Global Mupirocin Ointment Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Glenmark Pharms
- 4.1.1 Glenmark Pharms Company Information
- 4.1.2 Glenmark Pharms Business Overview
- 4.1.3 Glenmark Pharms Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Glenmark Pharms Mupirocin Ointment Product Portfolio
- 4.1.5 Glenmark Pharms Recent Developments
- 4.2 Glaxosmithkline
- 4.2.1 Glaxosmithkline Company Information
- 4.2.2 Glaxosmithkline Business Overview
- 4.2.3 Glaxosmithkline Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Glaxosmithkline Mupirocin Ointment Product Portfolio
- 4.2.5 Glaxosmithkline Recent Developments
- 4.3 SmithKline & French
- 4.3.1 SmithKline & French Company Information
- 4.3.2 SmithKline & French Business Overview
- 4.3.3 SmithKline & French Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SmithKline & French Mupirocin Ointment Product Portfolio
- 4.3.5 SmithKline & French Recent Developments
- 4.4 Humanwell Healthcare
- 4.4.1 Humanwell Healthcare Company Information
- 4.4.2 Humanwell Healthcare Business Overview
- 4.4.3 Humanwell Healthcare Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Humanwell Healthcare Mupirocin Ointment Product Portfolio
- 4.4.5 Humanwell Healthcare Recent Developments
- 4.5 Taro Pharmaceutical
- 4.5.1 Taro Pharmaceutical Company Information
- 4.5.2 Taro Pharmaceutical Business Overview
- 4.5.3 Taro Pharmaceutical Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Taro Pharmaceutical Mupirocin Ointment Product Portfolio
- 4.5.5 Taro Pharmaceutical Recent Developments
- 4.6 Teva
- 4.6.1 Teva Company Information
- 4.6.2 Teva Business Overview
- 4.6.3 Teva Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Teva Mupirocin Ointment Product Portfolio
- 4.6.5 Teva Recent Developments
- 4.7 Perrigo
- 4.7.1 Perrigo Company Information
- 4.7.2 Perrigo Business Overview
- 4.7.3 Perrigo Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Perrigo Mupirocin Ointment Product Portfolio
- 4.7.5 Perrigo Recent Developments
- 4.8 Hanzhou Zhuyangxin Pharmaceutical
- 4.8.1 Hanzhou Zhuyangxin Pharmaceutical Company Information
- 4.8.2 Hanzhou Zhuyangxin Pharmaceutical Business Overview
- 4.8.3 Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hanzhou Zhuyangxin Pharmaceutical Mupirocin Ointment Product Portfolio
- 4.8.5 Hanzhou Zhuyangxin Pharmaceutical Recent Developments
5 Global Mupirocin Ointment Market Scenario by Region
- 5.1 Global Mupirocin Ointment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Mupirocin Ointment Sales by Region: 2021-2032
- 5.2.1 Global Mupirocin Ointment Sales by Region: 2021-2026
- 5.2.2 Global Mupirocin Ointment Sales by Region: 2027-2032
- 5.3 Global Mupirocin Ointment Revenue by Region: 2021-2032
- 5.3.1 Global Mupirocin Ointment Revenue by Region: 2021-2026
- 5.3.2 Global Mupirocin Ointment Revenue by Region: 2027-2032
- 5.4 North America Mupirocin Ointment Market Facts & Figures by Country
- 5.4.1 North America Mupirocin Ointment Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Mupirocin Ointment Sales by Country (2021-2032)
- 5.4.3 North America Mupirocin Ointment Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Mupirocin Ointment Market Facts & Figures by Country
- 5.5.1 Europe Mupirocin Ointment Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Mupirocin Ointment Sales by Country (2021-2032)
- 5.5.3 Europe Mupirocin Ointment Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Mupirocin Ointment Market Facts & Figures by Country
- 5.6.1 Asia Pacific Mupirocin Ointment Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Mupirocin Ointment Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Mupirocin Ointment Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Mupirocin Ointment Market Facts & Figures by Country
- 5.7.1 South America Mupirocin Ointment Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Mupirocin Ointment Sales by Country (2021-2032)
- 5.7.3 South America Mupirocin Ointment Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Mupirocin Ointment Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Mupirocin Ointment Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Mupirocin Ointment Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Mupirocin Ointment Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Mupirocin Ointment Sales by Type (2021-2032)
- 6.1.1 Global Mupirocin Ointment Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Mupirocin Ointment Sales Market Share by Type (2021-2032)
- 6.2 Global Mupirocin Ointment Revenue by Type (2021-2032)
- 6.2.1 Global Mupirocin Ointment Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Mupirocin Ointment Revenue Market Share by Type (2021-2032)
- 6.3 Global Mupirocin Ointment Price by Type (2021-2032)
7 Segment by Sales Channel
- 7.1 Global Mupirocin Ointment Sales by Sales Channel (2021-2032)
- 7.1.1 Global Mupirocin Ointment Sales by Sales Channel (2021-2032) & (K Units)
- 7.1.2 Global Mupirocin Ointment Sales Market Share by Sales Channel (2021-2032)
- 7.2 Global Mupirocin Ointment Revenue by Sales Channel (2021-2032)
- 7.2.1 Global Mupirocin Ointment Sales by Sales Channel (2021-2032) & (US$ Million)
- 7.2.2 Global Mupirocin Ointment Revenue Market Share by Sales Channel (2021-2032)
- 7.3 Global Mupirocin Ointment Price by Sales Channel (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Mupirocin Ointment Value Chain Analysis
- 8.1.1 Mupirocin Ointment Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Mupirocin Ointment Production Mode & Process
- 8.2 Mupirocin Ointment Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Mupirocin Ointment Distributors
- 8.2.3 Mupirocin Ointment Customers
9 Global Mupirocin Ointment Analyzing Market Dynamics
- 9.1 Mupirocin Ointment Industry Trends
- 9.2 Mupirocin Ointment Industry Drivers
- 9.3 Mupirocin Ointment Industry Opportunities and Challenges
- 9.4 Mupirocin Ointment Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst